Antimony-trioxide- and arsenic-trioxide-induced apoptosis in myelogenic and lymphatic cell lines, recruitment of caspases, and loss of mitochondrial membrane potential are enhanced by modulators of the cellular glutathione redox system Susan LöslerSarah SchliefMarkus T. Rojewski Original Article 21 March 2009 Pages: 1047 - 1058
Opposite expression pattern of Src kinase Lyn in acute and chronic haematological malignancies Kais HusseinNils von NeuhoffOliver Bock Original Article 17 March 2009 Pages: 1059 - 1067
Additional chromosomal abnormalities and their prognostic significance in adult Philadelphia-positive acute lymphoblastic leukemia: with or without imatinib in chemotherapy Yenan LiLugui QiuJianxiang Wang Original Article 10 March 2009 Pages: 1069 - 1077
Risk factors for leukemia in Thailand David W. KaufmanTheresa E. AndersonSurapol Issaragrisil Original Article 18 March 2009 Pages: 1079 - 1088
Different clinical importance of FLT3 internal tandem duplications in AML according to FAB classification: possible existence of distinct leukemogenesis involving monocyte differentiation pathway Youngil KohJuwon ParkByung-Kook Kim Original Article 19 March 2009 Pages: 1089 - 1097
Treatment outcome of adult patients with Burkitt lymphoma: results using the LMB protocol in Korea Moon Ki ChoiHyun Jung JunSeok Jin Kim Original Article 14 March 2009 Pages: 1099 - 1106
Intermediate dose gemcitabine–cisplatin combination chemotherapy without treatment delay for cytopenia followed by autografting—a new standard of care in relapsed or refractory Hodgkin lymphoma? T. ToddS. RajR. Marcus Original Article 06 May 2009 Pages: 1107 - 1112
Induction of myeloma-specific cytotoxic T lymphocytes ex vivo by CD40-activated B cells loaded with myeloma tumor antigens Sang-Ki KimThanh-Nhan Nguyen PhamJe-Jung Lee Original Article 11 March 2009 Pages: 1113 - 1123
DSMM XI study: dose definition for intravenous cyclophosphamide in combination with bortezomib/dexamethasone for remission induction in patients with newly diagnosed myeloma Martin KropffPeter Liebischon behalf of the Deutsche Studiengruppe Multiples Myelom, DSMM Original Article Open access 10 March 2009 Pages: 1125 - 1130
Serum ferritin concentrations in Africans with low dietary iron Victor M. MoyoElisha MvunduraVictor R. Gordeuk Original Article 04 March 2009 Pages: 1131 - 1136
Cutaneous involvement in multiple myeloma and bortezomib A. SiniscalchiS. FratoniT. Caravita Letter to the Editor 04 March 2009 Pages: 1137 - 1139
Repeated responses of an elderly patient with high-risk myelodysplastic syndrome to sequential therapy with tipifarnib, 5-azacitidine, and decitabine Isabel MöllerSabine BlumAndrea Kuendgen Letter to the Editor 17 March 2009 Pages: 1141 - 1144
Diversity in clinical presentation of hemoglobin H disease induced by the SEA deletion and the hemoglobin Quong Sze Can LiaoJian LiDong-Zhi Li Letter to the Editor 04 March 2009 Pages: 1145 - 1147
A novel mutation of −50 (G→A) in the direct repeat element of the β-globin gene identified in a patient with severe β-thalassemia Dong-Zhi LiCan LiaoJian-Ying Zhou Letter to the Editor 17 March 2009 Pages: 1149 - 1150
Diagnostic complication and molecular characteristics of Hb SC-Chicago disease with α-thal-2 (-α3.7 deletion): effects of multiple variant on patient’s phenotype Heather Yaun HughesKathleen McKieFerdane Kutlar Letter to the Editor 17 April 2009 Pages: 1151 - 1153
Durable response to a single dose of Anti D in immune thrombocytopenic purpura in an adult with underlying human immunodeficiency viral infection Saman HewamanaChris PepperClare Rowntree Letter to the Editor 28 April 2009 Pages: 1155 - 1156
Isoderivative of deleted chromosome 20 in primary myelofibrosis (PMF) characterized by molecular cytogenetics and array CGH N. Douet-GuilbertJ. AndrieuxM. De Braekeleer Letter to the Editor 15 May 2009 Pages: 1157 - 1159
